Your browser doesn't support javascript.
loading
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.
Hakkaart, Christopher; Pearson, John F; Marquart, Louise; Dennis, Joe; Wiggins, George A R; Barnes, Daniel R; Robinson, Bridget A; Mace, Peter D; Aittomäki, Kristiina; Andrulis, Irene L; Arun, Banu K; Azzollini, Jacopo; Balmaña, Judith; Barkardottir, Rosa B; Belhadj, Sami; Berger, Lieke; Blok, Marinus J; Boonen, Susanne E; Borde, Julika; Bradbury, Angela R; Brunet, Joan; Buys, Saundra S; Caligo, Maria A; Campbell, Ian; Chung, Wendy K; Claes, Kathleen B M; Collonge-Rame, Marie-Agnès; Cook, Jackie; Cosgrove, Casey; Couch, Fergus J; Daly, Mary B; Dandiker, Sita; Davidson, Rosemarie; de la Hoya, Miguel; de Putter, Robin; Delnatte, Capucine; Dhawan, Mallika; Diez, Orland; Ding, Yuan Chun; Domchek, Susan M; Donaldson, Alan; Eason, Jacqueline; Easton, Douglas F; Ehrencrona, Hans; Engel, Christoph; Evans, D Gareth; Faust, Ulrike; Feliubadaló, Lidia; Fostira, Florentia; Friedman, Eitan.
Affiliation
  • Hakkaart C; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
  • Pearson JF; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
  • Marquart L; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Dennis J; School of Public Health, University of Queensland, Brisbane, Australia.
  • Wiggins GAR; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Barnes DR; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
  • Robinson BA; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Mace PD; Department of Medicine, University of Otago, Christchurch, New Zealand.
  • Aittomäki K; Canterbury Regional Cancer and Haematology Service, Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand.
  • Andrulis IL; Department of Biochemistry, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
  • Arun BK; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.
  • Azzollini J; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Balmaña J; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Barkardottir RB; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Belhadj S; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
  • Berger L; Hereditary cancer Genetics Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Hospital Campus, Barcelona, Spain.
  • Blok MJ; Department of Medical Oncology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Boonen SE; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
  • Borde J; BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Bradbury AR; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Brunet J; Department of Clinical Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Buys SS; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Caligo MA; Department of Clinical Genetics, Odense University Hospital, Odence C, Denmark.
  • Campbell I; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Chung WK; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Claes KBM; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Collonge-Rame MA; Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Cook J; SOD Genetica Molecolare, University Hospital, Pisa, Italy.
  • Cosgrove C; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
  • Couch FJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Daly MB; Departments of Pediatrics and Medicine, Columbia University, New York, NY, USA.
  • Dandiker S; Centre for Medical Genetics, Ghent University Hospital, Gent, Belgium.
  • de Putter R; Service de Génétique Biologique, CHRU de Besançon, Besançon, France.
  • Delnatte C; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
  • Dhawan M; Gynecologic Oncology, Translational Therapeutics, Department of Obstetrics and Gynecology, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Diez O; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Ding YC; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Domchek SM; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Donaldson A; Department of Clinical Genetics, Queen Elizabeth University Hospital, Glasgow, UK.
  • Eason J; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
  • Easton DF; Centre for Medical Genetics, Ghent University Hospital, Gent, Belgium.
  • Ehrencrona H; Oncogénétique, Institut de Cancérologie de l'Ouest siteRené Gauducheau, Saint Herblain, France.
  • Engel C; Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA, USA.
  • Evans DG; Hereditary cancer Genetics Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Hospital Campus, Barcelona, Spain.
  • Faust U; Area of Clinical and Molecular Genetics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Feliubadaló L; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
  • Fostira F; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Friedman E; Clinical Genetics Department, St Michael's Hospital, Bristol, UK.
Commun Biol ; 5(1): 1061, 2022 10 06.
Article in En | MEDLINE | ID: mdl-36203093
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Commun Biol Year: 2022 Document type: Article Affiliation country: Nueva Zelanda
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Commun Biol Year: 2022 Document type: Article Affiliation country: Nueva Zelanda